Status:
COMPLETED
Droperidol and Cardiac Repolarization
Lead Sponsor:
Medical University of Gdansk
Conditions:
Cardiac Repolarization
Eligibility:
MALE
18-60 years
Phase:
PHASE4
Brief Summary
For many years droperidol has been used in prophylaxis and therapy of PONV. Information that it can provoke disorders of cardiac ventricular rhythm reduced its popularity. However those data didn't ba...
Eligibility Criteria
Inclusion
- age 18-60 years
- sex: males
- ASA score I or II
Exclusion
- treatment with drugs influencing cardiac repolarization
- coronary artery disease
- heart insufficiency NYHA\>1
- serum electrolyte disturbances
- hypersensitivity to droperidol and/or ondansetron
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01819857
Start Date
June 1 2011
End Date
July 1 2013
Last Update
August 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Gdansk
Gdansk, Poland, 80-214